| Company Name: |
Daicel Chiral Technologies (China)CO.,LTD
|
| Tel: |
021-50460086-9 15921403865 |
| Email: |
han_yajun@dctc.daicel.com |
| Products Intro: |
Product Name:5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acid
CAS:2135333-04-7
Purity:95%HPLC Package:10MG;25MG;50MG;100MG Remarks:DCTI-C-2191
|
| Company Name: |
Cato Research Chemicals Inc.
|
| Tel: |
18933936954 |
| Email: |
2853283383@qq.com |
| Products Intro: |
Product Name:Vericiguat Impurity 14
CAS:2135333-04-7
Purity:97% Package:mg;10mg;25mg;50mg
|
|
| | 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid, 5-fluoro-1-[(2-fluorophenyl)methyl]- Basic information |
| | 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid, 5-fluoro-1-[(2-fluorophenyl)methyl]- Chemical Properties |
| Boiling point | 507.9±50.0 °C(Predicted) | | density | 1.49±0.1 g/cm3(Predicted) | | pka | 1.96±0.30(Predicted) |
| | 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid, 5-fluoro-1-[(2-fluorophenyl)methyl]- Usage And Synthesis |
| Uses | Vericiguat impurity-1 is the impurity of Vericiguat (HY-16774). Vericiguat impurity-1 can be used as impurity standards in impurity analysis, to develop selective and quantitative methods to determine impurities[1]. | | References | [1] Maggio RM, et al., Pharmaceutical impurities and degradation products: uses and applications of NMR techniques. J Pharm Biomed Anal. 2014 Dec;101:102-22. DOI:10.1016/j.jpba.2014.04.016 |
| | 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid, 5-fluoro-1-[(2-fluorophenyl)methyl]- Preparation Products And Raw materials |
|